Health Condition 1: 3- Administration
Conditions
Interventions
Intervention1: Intrathecal 0.5% hyperbaric bupivacaine (3 mL) with subcutaneous dexmedetomidine (0.5 mcg/kg): Patients will receive 3 mL of 0.5% hyperbaric bupivacaine intrathecally and
0.5 mcg/kg dex
Sponsors
Jubilee Mission Medical College and Research Institute
Eligibility
Inclusion criteria
Inclusion criteria: Patients aged 18 to 60 years American Society of Anaesthesiology physical status 1 to 2 Scheduled for elective lower limb surgeries under spinal anaesthesia Duration of surgery should be less than 150 minutes
Exclusion criteria
Exclusion criteria: Known hypersensitive to study drugs Contraindications to spinal anaesthesia Patients with baseline heart rate Patient complaints of pain during procedure Failed spinal anesthesia Addition of any other analgesic medication during procedure
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| duration of postoperative analgesia, measured by time to first request for analgesics.Timepoint: duration of postoperative analgesia, measured by time to first request for analgesics. | — |
Secondary
| Measure | Time frame |
|---|---|
| Hemodynamic parameters monitored intraoperativelyTimepoint: From initiation of spinal anesthesia until the end of surgery (measured at baseline, every 3 minutes for the first 30 minutes, and then every 10 minutes until completion of surgery);Duration of sensory and motor block, assessed by standardised scales and time to regressionTimepoint: From administration of intrathecal anesthesia until complete regression of sensory and motor block, assessed at regular intervals;To evaluate overall patients satisfaction post operative.Timepoint: At 24 hours after surgery | — |
Countries
India
Contacts
Public ContactDr Davies C V
Jubilee Mission Medical College and Research Institute
Outcome results
None listed